Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
ReCode Therapeutics other respiratory mRNA program
- Development stage
- Preclinical
- Lead developer
- ReCode Therapeutics
- Modality
- mRNA Therapeutics → RNA Therapeutics → Nucleic Acid Therapeutics, Lipid-based Nanoparticles → Nanoparticles → Drug Delivery Systems
- Administration
- Inhalation
01
Overview
This is an undisclosed mRNA-based therapeutic program being developed by ReCode Therapeutics for the treatment of various respiratory indications. The program utilizes ReCode's proprietary Selective Organ Targeting (SORT) lipid nanoparticle (LNP) delivery platform, which is designed to enable the precise delivery of genetic medicines to specific organs, in this case, the lungs. While the specific molecular targets and exact respiratory diseases are not yet disclosed, the therapy is intended for inhalation to provide localized treatment within the respiratory system. It is currently in the discovery stage of development.
- Other names
- Other respiratory program
02
Targets
DNAI1 (Dynein axonemal intermediate chain 1)
Beyond the preview
Go deeper on ReCode Therapeutics other respiratory mRNA program.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on ReCode Therapeutics other respiratory mRNA program.